Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The increasing prevalence of obesity and type 2 diabetes mellitus (T2DM) presents a major global health challenge, as many existing therapies lack adequate efficacy and safety. As a triple-action agonist, retatrutide enhances satiety, suppresses hunger and boosts energy expenditure, potentially providing superior benefits for blood sugar control and weight loss compared to other incretin-based therapies
Vomiting : Along with nausea, some people may also experience vomiting, particularly if they eat large meals or foods that are rich or high in fat
Genetic predispositions interact with lifestyle, medical history, medication adherence, and other factors that collectively influence clinical results
eLife (2014) 3:e02523
